Model Details

Patient Information for Model: TCH-AML002

Patient Information
Clinical Timeline


Clinical Information at Collection
Clinical Biomarkers/Mutations

Model Information for Model: TCH-AML002

Model Details - Initial Implantation of Patient Tissue
Mutations (Cancer Gene Census List)
Mutation data is currently not available.

CNV


Histology Information for Model: TCH-AML002
There are no histology images for this model.













Metastasis Information for Model: TCH-AML002
 
Patient
PDX
Central Nervous System
Gingiva
Liver
None
Orbital chloroma
Skin
Spleen
Testis
lymph nodes
retinas
tongue

Patient Treatment Information for Model: TCH-AML002

Event IdTreatmentTreatment SettingAge at StartAge at EndDurationClinical ResponseMeasurable Residual Disease
10Cytarabine/IdarubicinDe Novo20.060.0UnknownInduction Failure
15Cytarabine/FludarabineRefractory20.250.0UnknownResidual Disease
20clo/topotecan/vinorelbine/thiotepaRefractory20.370.0UnknownResidual Disease
25azacitidine/venetoclaxRefractory20.540.0Unknown
30venetoclaxRefractory20.660.0UnknownRemission.16%
50decitabine/venetoclax then DLIRelapse21.30.0UnknownRelapse14%
60decitabine/venetoclax then DLIRelapse21.40.0UnknownRelapse4%














Timeout
Your session is about to expire. Click 'Stay Connected' to continue the session.